{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:54:58Z","timestamp":1790906098370,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ccl.2026.06.004","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:22:24Z","timestamp":1784114544000},"page":"635-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interventional and Device-Based Approaches for Epicardial and Microvascular Dysfunction"],"prefix":"10.1016","volume":"44","author":[{"given":"Daniele Oreste","family":"d\u2032Atri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ccl.2026.06.004_bib1","first-page":"S50","article-title":"Patients with coronary artery disease unsuitable for revascularization: definition, general principles, and a classification","volume":"28","author":"Jolicoeur","year":"2012","journal-title":"Can J Cardiol"},{"issue":"36","key":"10.1016\/j.ccl.2026.06.004_bib2","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ccl.2026.06.004_bib3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici","year":"2007","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ccl.2026.06.004_bib4","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of ischemic heart disease: fundamental role of coronary microvascular dysfunction in the pathogenesis of angina pectoris","volume":"138","author":"Kaski","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2026.06.004_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrcardio.2013.200","article-title":"Treatment of refractory angina in patients not suitable for revascularization","volume":"11","author":"Henry","year":"2014","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"10.1016\/j.ccl.2026.06.004_bib6","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","article-title":"Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease","volume":"8","author":"Sara","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"34","key":"10.1016\/j.ccl.2026.06.004_bib7","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/eurheartj\/eht165","article-title":"Long-term survival in patients with refractory angina","volume":"34","author":"Henry","year":"2013","journal-title":"Eur Heart J"},{"issue":"35","key":"10.1016\/j.ccl.2026.06.004_bib8","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1093\/eurheartj\/ehv391","article-title":"Appropriateness of percutaneous revascularization of coronary chronic total occlusions: an overview","volume":"37","author":"Galassi","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2026.06.004_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jacc.2005.11.093","article-title":"Determinants of coronary steal in chronic total coronary occlusions","volume":"48","author":"Werner","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ccl.2026.06.004_bib10","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/hc3401.095098","article-title":"Microvascular dysfunction in chronic total coronary occlusions","volume":"104","author":"Werner","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccl.2026.06.004_bib11","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.4244\/EIJ-D-21-00702","article-title":"Impact of percutaneous coronary intervention of chronic total occlusions on absolute perfusion in remote myocardium","volume":"18","author":"de Winter","year":"2022","journal-title":"EuroIntervention"},{"issue":"7","key":"10.1016\/j.ccl.2026.06.004_bib12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00392-023-02298-x","article-title":"Temporal trends of case-fatality in patients undergoing dual-injection coronary chronic total occlusion recanalization","volume":"113","author":"Blessing","year":"2024","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"10.1016\/j.ccl.2026.06.004_bib13","doi-asserted-by":"crossref","first-page":"e804","DOI":"10.4244\/EIJ-D-19-00282","article-title":"Coronary artery perforation during chronic total occlusion percutaneous coronary intervention: epidemiology, mechanisms, management, and outcomes","volume":"15","author":"Azzalini","year":"2019","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.ccl.2026.06.004_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4244\/EIJV15I2A27","article-title":"Chronic total occlusion percutaneous coronary intervention: the road ahead","volume":"15","author":"Brilakis","year":"2019","journal-title":"EuroIntervention"},{"issue":"18","key":"10.1016\/j.ccl.2026.06.004_bib15","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/heartjnl-2015-308891","article-title":"Hybrid approach improves success of chronic total occlusion angioplasty","volume":"102","author":"Wilson","year":"2016","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.ccl.2026.06.004_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4244\/EIJ-E-23-00040","article-title":"Reconsidering the evidence for CTO PCI: the devil is in the detail","volume":"19","author":"Al-Lamee","year":"2023","journal-title":"EuroIntervention"},{"issue":"7","key":"10.1016\/j.ccl.2026.06.004_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4244\/EIJ-D-23-00312","article-title":"Three-year outcomes of A randomized multicentre trial comparing revascularization and optimal medical therapy for chronic total coronary occlusions (EuroCTO)","volume":"19","author":"Werner","year":"2023","journal-title":"EuroIntervention"},{"issue":"13","key":"10.1016\/j.ccl.2026.06.004_bib18","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jcin.2018.04.017","article-title":"The IMPACTOR-CTO trial","volume":"11","author":"Obedinskiy","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"14","key":"10.1016\/j.ccl.2026.06.004_bib19","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/CIRCULATIONAHA.118.031313","article-title":"Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion","volume":"139","author":"Lee","year":"2019","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ccl.2026.06.004_bib20","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jcin.2022.05.023","article-title":"Comparative analysis of patient characteristics in chronic total occlusion revascularization studies","volume":"15","author":"Megaly","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.ccl.2026.06.004_bib21","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.4244\/EIJ-D-23-00490","article-title":"Contemporary outcomes of chronic total occlusion percutaneous coronary intervention in Europe: the ERCTO registry","volume":"20","author":"Vadal\u00e0","year":"2024","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.ccl.2026.06.004_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2021.09.027","article-title":"Contemporary issues in chronic total occlusion percutaneous coronary intervention","volume":"15","author":"Azzalini","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.ccl.2026.06.004_bib23","first-page":"629","article-title":"Quality of life benefits of percutaneous coronary intervention for chronic occlusions","volume":"84","author":"Safley","year":"2014","journal-title":"Cathet Cardiovasc Interv"},{"issue":"13","key":"10.1016\/j.ccl.2026.06.004_bib24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4244\/EIJY20M07_01","volume":"16","author":"Kunadian","year":"2021","journal-title":"EuroIntervention"},{"issue":"13","key":"10.1016\/j.ccl.2026.06.004_bib25","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/jama.1955.02960300008003","article-title":"Scientific basis for the surgical treatment of coronary artery disease","volume":"159","author":"Beck","year":"1955","journal-title":"J Am Med Assoc"},{"issue":"8","key":"10.1016\/j.ccl.2026.06.004_bib26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/heartjnl-2012-303305","article-title":"Effects of coronary sinus occlusion on myocardial ischaemia in humans: role of coronary collateral function","volume":"99","author":"Stoller","year":"2013","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ccl.2026.06.004_bib27","doi-asserted-by":"crossref","first-page":"H1361","DOI":"10.1152\/ajpheart.2001.280.3.H1361","article-title":"Coronary sinus occlusion enhances coronary collateral flow and reduces subendocardial ischemia","volume":"280","author":"Ido","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"14","key":"10.1016\/j.ccl.2026.06.004_bib28","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jcin.2022.05.039","article-title":"Transcatheter coronary sinus interventions","volume":"15","author":"Alkhouli","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"14","key":"10.1016\/j.ccl.2026.06.004_bib29","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.4244\/EIJ-D-18-01180","article-title":"Technical aspects in coronary sinus reducer implantation","volume":"15","author":"Giannini","year":"2020","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.ccl.2026.06.004_bib30","first-page":"120","article-title":"Incomplete coronary sinus reducer endothelialization as potential mechanism of clinical failure","volume":"94","author":"Zivelonghi","year":"2019","journal-title":"Cathet Cardiovasc Interv"},{"issue":"24","key":"10.1016\/j.ccl.2026.06.004_bib31","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1016\/j.jacc.2018.09.061","article-title":"First-in-human use of coronary sinus reducer in patients with refractory angina","volume":"72","author":"Parikh","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.ccl.2026.06.004_bib32","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jcin.2017.06.062","article-title":"First experience with the coronary sinus reducer system for the management of refractory angina in patients without obstructive coronary artery disease","volume":"10","author":"Giannini","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"10.1016\/j.ccl.2026.06.004_bib33","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.jacc.2007.01.061","article-title":"Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris","volume":"49","author":"Banai","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2026.06.004_bib34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1402556","article-title":"Efficacy of a device to narrow the coronary sinus in refractory angina","volume":"372","author":"Verheye","year":"2015","journal-title":"N Engl J Med"},{"issue":"10436","key":"10.1016\/j.ccl.2026.06.004_bib35","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(24)00256-3","article-title":"Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial","volume":"403","author":"Foley","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ccl.2026.06.004_bib36","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.4244\/EIJ-D-18-00102","article-title":"Coronary sinus reducer implantation improves symptoms, ischaemia and physical capacity in patients with refractory angina unsuitable for myocardial revascularisation: a single-centre experience","volume":"14","author":"Konigstein","year":"2018","journal-title":"EuroIntervention"},{"issue":"24","key":"10.1016\/j.ccl.2026.06.004_bib37","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/j.jcin.2024.08.047","article-title":"Coronary sinus narrowing for treating refractory angina","volume":"17","author":"Verheye","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"10.1016\/j.ccl.2026.06.004_bib38","doi-asserted-by":"crossref","first-page":"e1511","DOI":"10.4244\/EIJ-D-19-00766","article-title":"Effects of coronary sinus reducer implantation on oxygen kinetics in patients with refractory angina","volume":"16","author":"Zivelonghi","year":"2021","journal-title":"EuroIntervention"},{"issue":"9","key":"10.1016\/j.ccl.2026.06.004_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009148","article-title":"Patterns of regional myocardial perfusion following coronary sinus reducer implantation","volume":"12","author":"Giannini","year":"2019","journal-title":"Circ, Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ccl.2026.06.004_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013481","article-title":"Coronary sinus narrowing improves coronary microcirculation function in patients with refractory angina: a multicenter prospective INROAD study","volume":"17","author":"Tebaldi","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.ccl.2026.06.004_bib41","first-page":"2313","article-title":"Impact of coronary sinus reducer on angina symptoms in patients with myocardial ischemia without obstructive coronary artery disease","volume":"106","author":"Giannini","year":"2025","journal-title":"Cathet Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.ccl.2026.06.004_bib42","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamacardio.2023.2566","article-title":"Coronary venous pressure and microvascular hemodynamics in patients with microvascular angina: a randomized clinical trial","volume":"8","author":"Ullrich","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2026.06.004_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002743","article-title":"Coronary venous interventions","volume":"8","author":"Faxon","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"issue":"24","key":"10.1016\/j.ccl.2026.06.004_bib44","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.jcin.2024.09.018","article-title":"Coronary sinus reducer improves angina, quality of life, and coronary flow reserve in microvascular dysfunction","volume":"17","author":"Tryon","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.ccl.2026.06.004_bib45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/hrt.2009.184507","article-title":"Coronary collateral growth by external counterpulsation: a randomised controlled trial","volume":"96","author":"Gloekler","year":"2010","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.ccl.2026.06.004_bib46","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1365-2362.2009.02192.x","article-title":"Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.-2 trial)","volume":"39","author":"Buschmann","year":"2009","journal-title":"Eur J Clin Invest"},{"issue":"16","key":"10.1016\/j.ccl.2026.06.004_bib47","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1053\/euhj.2000.2545","article-title":"Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina. Evaluation by13N-ammonia positron emission tomography","volume":"22","author":"Masuda","year":"2001","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ccl.2026.06.004_bib48","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0735-1097(03)00329-2","article-title":"Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease","volume":"41","author":"Bonetti","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2026.06.004_bib49","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jacc.2006.04.094","article-title":"Enhanced external counterpulsation treatment improves arterial wall properties and wave reflection characteristics in patients with refractory angina","volume":"48","author":"Nichols","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.ccl.2026.06.004_bib50","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.109.923482","article-title":"Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina","volume":"122","author":"Braith","year":"2010","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccl.2026.06.004_bib51","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0735-1097(99)00140-0","article-title":"The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes","volume":"33","author":"Arora","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2026.06.004_bib52","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1592\/phco.30.7.639","article-title":"Impact of enhanced external counterpulsation on Canadian cardiovascular society angina class in patients with chronic stable angina: a meta-analysis","volume":"30","author":"Shah","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"47","key":"10.1016\/j.ccl.2026.06.004_bib53","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002002","article-title":"Efficacy of enhanced external counterpulsation in patients with chronic refractory angina on canadian cardiovascular society (CCS) angina class","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.ccl.2026.06.004_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151822","article-title":"Does enhanced external counterpulsation (EECP) significantly affect myocardial perfusion?: a systematic review & meta-analysis","volume":"11","author":"Qin","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ccl.2026.06.004_bib55","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S0266462310000073","article-title":"Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United Kingdom","volume":"26","author":"McKenna","year":"2010","journal-title":"Int J Technol Assess Health Care"},{"issue":"16","key":"10.1016\/j.ccl.2026.06.004_bib56","first-page":"5402","article-title":"Cardiac shock wave therapy: an alternative non-invasive therapy for refractory angina","volume":"22","author":"Li","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.ccl.2026.06.004_bib57","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.mayocp.2013.11.017","article-title":"Safety and efficacy of extracorporeal shock wave myocardial revascularization therapy for refractory angina pectoris","volume":"89","author":"Cassar","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"19","key":"10.1016\/j.ccl.2026.06.004_bib58","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1161\/01.CIR.0000148849.51177.97","article-title":"Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo","volume":"110","author":"Nishida","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccl.2026.06.004_bib59","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jacc.2005.05.052","article-title":"Treatment of ischemic limbs based on local recruitment of vascular endothelial growth factor-producing inflammatory cells with ultrasonic microbubble destruction","volume":"46","author":"Yoshida","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2026.06.004_bib60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.niox.2004.12.005","article-title":"Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production","volume":"12","author":"Mariotto","year":"2005","journal-title":"Nitric Oxide"},{"issue":"25","key":"10.1016\/j.ccl.2026.06.004_bib61","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1161\/CIRCULATIONAHA.106.628623","article-title":"Low-energy shock wave for enhancing recruitment of endothelial progenitor cells","volume":"114","author":"Aicher","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2026.06.004_bib62","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/MCA.0000000000000218","article-title":"Extracorporeal shockwave myocardial therapy is efficacious in improving symptoms in patients with refractory angina pectoris \u2013 a multicenter study","volume":"26","author":"Prasad","year":"2015","journal-title":"Coron Artery Dis"},{"issue":"1","key":"10.1016\/j.ccl.2026.06.004_bib63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.carrev.2014.10.011","article-title":"The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina","volume":"16","author":"Alunni","year":"2015","journal-title":"Cardiovasc Revascularization Med"},{"issue":"8","key":"10.1016\/j.ccl.2026.06.004_bib64","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.carrev.2017.05.006","article-title":"The beneficial effect of extracorporeal shockwave myocardial revascularization: two years of follow-up","volume":"18","author":"Alunni","year":"2017","journal-title":"Cardiovasc Revascularization Med"},{"issue":"1","key":"10.1016\/j.ccl.2026.06.004_bib65","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00380-018-1215-4","article-title":"A multicenter trial of extracorporeal cardiac shock wave therapy for refractory angina pectoris: report of the highly advanced medical treatment in Japan","volume":"34","author":"Kikuchi","year":"2019","journal-title":"Heart Vessel"},{"issue":"5","key":"10.1016\/j.ccl.2026.06.004_bib66","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s12471-016-0821-y","article-title":"Cardiac shockwave therapy in patients with chronic refractory angina pectoris","volume":"24","author":"Vainer","year":"2016","journal-title":"Neth Heart J"},{"issue":"3","key":"10.1016\/j.ccl.2026.06.004_bib67","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-5922.2012.00313.x","article-title":"Cardiac shock wave therapy for chronic refractory angina pectoris. A prospective placebo-controlled randomized trial","volume":"31","author":"Schmid","year":"2013","journal-title":"Cardiovasc Ther"},{"issue":"1","key":"10.1016\/j.ccl.2026.06.004_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12947-017-0102-y","article-title":"Cardiac shock-wave therapy in the treatment of coronary artery disease: systematic review and meta-analysis","volume":"15","author":"Burneikait\u0117","year":"2017","journal-title":"Cardiovasc Ultrasound"},{"issue":"1","key":"10.1016\/j.ccl.2026.06.004_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2019.08.055","article-title":"Refractory angina","volume":"13","author":"Gallone","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.ccl.2026.06.004_bib70","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/heart.87.6.513","article-title":"Central neural contribution to the perception of chest pain in cardiac syndrome X","volume":"87","author":"Rosen","year":"2002","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ccl.2026.06.004_bib71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2261-7-18","article-title":"The effect of electrical neurostimulation on collateral perfusion during acute coronary occlusion","volume":"7","author":"de Vries","year":"2007","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"10.1016\/j.ccl.2026.06.004_bib72","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ehjci\/jeu276","article-title":"Effect of spinal cord stimulation on myocardial perfusion reserve in patients with refractory angina pectoris","volume":"16","author":"Saraste","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ccl.2026.06.004_bib73","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ner.12349","article-title":"The effectiveness and cost-effectiveness of spinal cord stimulation for refractory angina (RASCAL study): a pilot randomized controlled trial","volume":"19","author":"Eldabe","year":"2016","journal-title":"Neuromodulation"},{"issue":"10","key":"10.1016\/j.ccl.2026.06.004_bib74","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/eurheartj\/ehi089","article-title":"Effect of spinal cord stimulation on spontaneous and stress-induced angina and \u2018ischemia-like\u2019 ST-segment depression in patients with cardiac syndrome X","volume":"26","author":"Lanza","year":"2005","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ccl.2026.06.004_bib75","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/hrt.2006.100784","article-title":"Thoracic spinal cord stimulation improves functional status and relieves symptoms in patients with refractory angina pectoris: the first placebo-controlled randomised study","volume":"93","author":"Eddicks","year":"2007","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.ccl.2026.06.004_bib76","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1525-1403.2012.00452.x","article-title":"Spinal cord stimulation therapy for patients with refractory angina who are not candidates for revascularization","volume":"15","author":"Zipes","year":"2012","journal-title":"Neuromodulation"},{"key":"10.1016\/j.ccl.2026.06.004_bib77","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ijcard.2016.10.105","article-title":"Efficacy of spinal cord stimulation as an adjunct therapy for chronic refractory angina pectoris","volume":"227","author":"Imran","year":"2017","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2026.06.004_bib78","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/AJP.0000000000000435","article-title":"Spinal cord stimulation for refractory angina pectoris","volume":"33","author":"Pan","year":"2017","journal-title":"Clin J Pain"},{"issue":"1","key":"10.1016\/j.ccl.2026.06.004_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeac083","article-title":"Neuromodulation in patients with refractory angina pectoris: a review","volume":"3","author":"Vervaat","year":"2023","journal-title":"European Heart Journal Open"},{"key":"10.1016\/j.ccl.2026.06.004_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1681623","article-title":"Prospective evaluation of spinal cord stimulation in refractory angina: insights from a single-center cohort","volume":"12","author":"Gasimova","year":"2025","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"10.1016\/j.ccl.2026.06.004_bib81","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00019501-199309000-00009","article-title":"Spinal cord stimulation in angina pectoris with normal coronary arteriograms","volume":"4","author":"MD","year":"1993","journal-title":"Coron Artery Dis"},{"issue":"6","key":"10.1016\/j.ccl.2026.06.004_bib82","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1525-1403.2012.00430.x","article-title":"Effect of spinal cord stimulation in patients with refractory angina: evidence from observational studies","volume":"15","author":"Lanza","year":"2012","journal-title":"Neuromodulation"},{"issue":"8","key":"10.1016\/j.ccl.2026.06.004_bib83","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/cvr\/cvaa027","article-title":"Promise of autologous CD34+ stem\/progenitor cell therapy for treatment of cardiovascular disease","volume":"116","author":"Prasad","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.ccl.2026.06.004_bib84","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCRESAHA.116.304187","article-title":"Circulating CD34 + progenitor cells and risk of mortality in a population with coronary artery disease","volume":"116","author":"Patel","year":"2015","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.ccl.2026.06.004_bib85","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1089\/lrb.2005.3.234","article-title":"Circulating endothelial progenitor cells and vascular anomalies","volume":"3","author":"Kleinman","year":"2005","journal-title":"Lymphatic Res Biol"},{"issue":"20","key":"10.1016\/j.ccl.2026.06.004_bib86","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/CIRCULATIONAHA.106.644518","article-title":"CD34-Positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells","volume":"114","author":"Kawamoto","year":"2006","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ccl.2026.06.004_bib87","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1161\/CIRCULATIONAHA.106.687376","article-title":"Intramyocardial transplantation of autologous CD34 + stem cells for intractable angina","volume":"115","author":"Losordo","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccl.2026.06.004_bib88","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.245993","article-title":"Intramyocardial, autologous CD34+ cell therapy for refractory angina","volume":"109","author":"Losordo","year":"2011","journal-title":"Circ Res"},{"issue":"23","key":"10.1016\/j.ccl.2026.06.004_bib89","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/eurheartj\/ehx764","article-title":"Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials","volume":"39","author":"Henry","year":"2018","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.ccl.2026.06.004_bib90","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jcin.2016.05.003","article-title":"The RENEW trial","volume":"9","author":"Povsic","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.ccl.2026.06.004_bib91","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.010802","article-title":"Autologous CD34+ stem cell therapy increases coronary flow reserve and reduces angina in patients with coronary microvascular dysfunction","volume":"15","author":"Henry","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.ccl.2026.06.004_bib92","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13287-018-0969-z","article-title":"Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO)","volume":"9","author":"Bassetti","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.ccl.2026.06.004_bib93","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCRESAHA.116.309009","article-title":"Effects of transendocardial delivery of bone marrow\u2013derived CD133 + cells on left ventricle perfusion and function in patients with refractory angina","volume":"120","author":"Wojakowski","year":"2017","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.ccl.2026.06.004_bib94","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/CIRCRESAHA.115.303463","article-title":"Selected CD133 + progenitor cells to promote angiogenesis in patients with refractory angina","volume":"115","author":"Jimenez-Quevedo","year":"2014","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.ccl.2026.06.004_bib95","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1097\/CCM.0000000000003051","article-title":"The five-year clinical and angiographic Follow-Up outcomes of intracoronary transfusion of circulation-derived CD34+ cells for patients with end-stage diffuse coronary artery disease unsuitable for coronary intervention\u2014phase I clinical trial","volume":"46","author":"Sung","year":"2018","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.ccl.2026.06.004_bib96","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/CCM.0000000000001138","article-title":"Intracoronary transfusion of circulation-derived CD34+ cells improves left ventricular function in patients with end-stage diffuse coronary artery disease unsuitable for coronary intervention","volume":"43","author":"Lee","year":"2015","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccl.2026.06.004_bib97","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCRESAHA.115.308056","article-title":"Impact of cell therapy on myocardial perfusion and cardiovascular outcomes in patients with angina refractory to medical therapy","volume":"118","author":"Khan","year":"2016","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.ccl.2026.06.004_bib98","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.RES.0000150856.47324.5b","article-title":"Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction","volume":"95","author":"Kucia","year":"2004","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.ccl.2026.06.004_bib99","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/CIRCRESAHA.118.314118","article-title":"The impact of cell therapy on cardiovascular outcomes in patients with refractory angina","volume":"124","author":"Jones","year":"2019","journal-title":"Circ Res"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865126000664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865126000664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:18:34Z","timestamp":1790903914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865126000664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0733865126000664"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2026.06.004","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interventional and Device-Based Approaches for Epicardial and Microvascular Dysfunction","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2026.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}